webinar register page

Webinar banner
Overview of a Study to Evaluate the Efficacy and Safety of an Investigational Drug in Adult Patients with Bullous Pemphigoid (LIBERTY-BP) is the focus of the March webinar
Overview of a Study to Evaluate the Efficacy and Safety of an Investigational Drug in Adult Patients with Bullous Pemphigoid (LIBERTY-BP) is the focus of the March webinar. This webinar is intended for U.S. listeners only.

Who will be on the webinar?

Arsalan Shabbir MD, Ph.D., Regeneron Pharmaceuticals

When?
Tuesday, March 28th
Pacific Time: 10:00 am to 11:00 am
Mountain Time: 11:00 am to 12:00 pm
Central Time: 12:00 pm to 1:00 pm
Eastern Time: 1:00 pm to 2:00 pm

If you have a question, please submit all questions by March 2nd by 7:00 pm EST to amethyst@pemphigus.org.

This program is sponsored in part by Sanofi and Regeneron.

Mar 28, 2023 10:00 AM in Pacific Time (US and Canada)

Webinar logo
* Required information
Loading
Register

Speakers

Arsalan Shabbir MD, PhD
Arsalan Shabbir MD, PhD recieved his medical school training at the University at Buffalo School of Medicine and completed his dermatology residency at the University at Miami School of Medicine. He has been working in clinical development for over ten years in the fields of stem cell biology and immunology.

Share via Email

All fields are required
 

Switch Time Zone